{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:43:31Z","timestamp":1788122611798,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00520-018-4586-2","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T16:32:54Z","timestamp":1546533174000},"page":"783-791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Radiation-induced nausea and vomiting: a comparison between MASCC\/ESMO, ASCO, and NCCN antiemetic guidelines"],"prefix":"10.1007","volume":"27","author":[{"given":"Erin","family":"McKenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearl","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"DeAngelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Pidduck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen","family":"Razvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Bushehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"issue":"1","key":"4586_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2012.02.031","volume":"84","author":"K Dennis","year":"2012","unstructured":"Dennis K, Zhang L, Lutz S, van Baardwijk A, van der Linden Y, Holt T, Arnalot PF, Lagrange JL, Maranzano E, Liu R, Wong KH, Wong LC, Vassiliou V, Corn BW, de Angelis C, Holden L, Wong CS, Chow E (2012) International patterns of practice in the management of radiation therapy-induced nausea and vomiting. Int J Radiat Oncol Biol Phys 84(1):49\u201360. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2012.02.031","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4586_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.radonc.2009.11.001","volume":"94","author":"E Maranzano","year":"2009","unstructured":"Maranzano E, De Angelis V, Pergolizzi S, Lupattelli M, Frata P, Spagnesi S et al (2009) A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres. Radiother Oncol 94(1):36\u201341. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2009.11.001.","journal-title":"Radiother Oncol"},{"issue":"7","key":"4586_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3109\/02841869209083868","volume":"31","author":"R Henriksson","year":"1992","unstructured":"Henriksson R, Lomberg H, Israelsson G, Zackrisson B, Franz\u00e9n L (1992) The effect of ondansetron on radiation-induced emesis and diarrhoea. Acta Oncol 31(7):767\u2013769","journal-title":"Acta Oncol"},{"issue":"1","key":"4586_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00520-008-0445-x","volume":"17","author":"A Enblom","year":"2008","unstructured":"Enblom A, Bergius Axelsson B, Steineck G, Hammar M, B\u00f6rjeson S (2008) One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient. Support Care Cancer 17(1):23\u201332. \n                    https:\/\/doi.org\/10.1007\/s00520-008-0445-x","journal-title":"Support Care Cancer"},{"issue":"3","key":"4586_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00520-012-1574-9","volume":"21","author":"C Pirri","year":"2013","unstructured":"Pirri C, Bayliss E, Trotter J, Olver IN, Katris P, Drummond P, Bennett R (2013) Nausea still the poor relation in antiemetic therapy? The impact on cancer patients\u2019 quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer 21(3):735\u2013748. \n                    https:\/\/doi.org\/10.1007\/s00520-012-1574-9","journal-title":"Support Care Cancer"},{"issue":"3","key":"4586_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s005200050163","volume":"6","author":"PC Feyer","year":"1998","unstructured":"Feyer PC, Stewart AL, Titlbach OJ (1998) Aetiology and prevention of emesis induced by radiotherapy. Support Care Cancer 6(3):253\u2013260","journal-title":"Support Care Cancer"},{"issue":"8","key":"4586_CR7","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00520-011-1258-x","volume":"20","author":"K Dennis","year":"2012","unstructured":"Dennis K, Nguyen J, Presutti R, DeAngelis C, Tsao M, Danjoux C, Barnes E, Sahgal A, Holden L, Jon F, Wong S, Chow E (2012) Prophylaxis of radiotherapy-induced nausea and vomiting in the palliative treatment of bone metastases. Support Care Cancer 20(8):1673\u20131678. \n                    https:\/\/doi.org\/10.1007\/s00520-011-1258-x","journal-title":"Support Care Cancer"},{"issue":"2","key":"4586_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0167-8140(97)00099-6","volume":"45","author":"N Aass","year":"1997","unstructured":"Aass N, H\u00e5tun DE, Thoresen M, Foss\u00e5 SD (1997) Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients. Radiother Oncol 45(2):125\u2013128","journal-title":"Radiother Oncol"},{"issue":"9","key":"4586_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00520-004-0766-3","volume":"13","author":"P Feyer","year":"2005","unstructured":"Feyer P, Seegenschmiedt MH, Steingraeber M (2005) Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies. Support Care Cancer 13(9):671\u2013678. \n                    https:\/\/doi.org\/10.1007\/s00520-004-0766-3","journal-title":"Support Care Cancer"},{"issue":"8","key":"4586_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1081\/CNV-100107736","volume":"19","author":"R Lanciano","year":"2001","unstructured":"Lanciano R, Sherman DM, Michalski J, Preston AJ, Yocom K, Friedman C (2001) The efficacy and safety of once-daily Kytril\u00ae (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy. Cancer Investig 19(8):763\u2013772","journal-title":"Cancer Investig"},{"issue":"2","key":"4586_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0936-6555(05)80790-3","volume":"2","author":"TJ Priestman","year":"1990","unstructured":"Priestman TJ, Roberts JT, Lucraft H, Collis CH, Adams M, Upadhyaya BK, Priestman S (1990) Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation. Clin Oncol 2(2):71\u201375","journal-title":"Clin Oncol"},{"issue":"6","key":"4586_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0936-6555(05)80086-X","volume":"5","author":"TJ Priestman","year":"1993","unstructured":"Priestman TJ, Roberts JT, Upadhyaya BK (1993) A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy. Clin Oncol 5(6):358\u2013363","journal-title":"Clin Oncol"},{"issue":"5","key":"4586_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0009-9260(79)80203-2","volume":"30","author":"CE Danjoux","year":"1979","unstructured":"Danjoux CE, Rider WD, Fitzpatrick PJ (1979) The acute radiation syndrome: a memorial to William Michael Court-Brown. Clin Radiol 30(5):581\u2013584","journal-title":"Clin Radiol"},{"issue":"21","key":"4586_CR14","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1200\/JCO.2005.04.4685","volume":"24","author":"RKS Wong","year":"2006","unstructured":"Wong RKS, Paul N, Ding K, Whitehead M, Brundage M, Fyles A et al (2006) 5-Hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19). J Clin Oncol 24(21):3458\u20133464. \n                    https:\/\/doi.org\/10.1200\/JCO.2005.04.4685","journal-title":"J Clin Oncol"},{"issue":"9","key":"4586_CR15","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1200\/JCO.2000.18.9.1960","volume":"18","author":"P Kirkbride","year":"2000","unstructured":"Kirkbride P, Bezjak A, Pater J, Zee B, Palmer MJ, Wong R, Cross P, Gulavita S, Blood P, Sun A, Dundas G, Ganguly PK, Lim J, Chowdhury AD, Kumar SE, Dar AR (2000) Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group Phase III Study. J Clin Oncol 18(9):1960\u20131966. \n                    https:\/\/doi.org\/10.1200\/JCO.2000.18.9.1960","journal-title":"J Clin Oncol"},{"issue":"1","key":"4586_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pbb.2005.07.007","volume":"82","author":"K Yamamoto","year":"2005","unstructured":"Yamamoto K, Nohara K, Furuya T, Yamatodani A (2005) Ondansetron, dexamethasone and an NK1 antagonist block radiation sickness in mice. Pharmacol Biochem Behav 82(1):24\u201329. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2005.07.007","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"4586_CR17","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3747\/co.21.2051","volume":"21","author":"K Dennis","year":"2014","unstructured":"Dennis K, De Angelis C, Jon F, Lauzon N, Pasetka M, Holden L et al (2014) Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study. Curr Oncol 21(6):760\u2013e767. \n                    https:\/\/doi.org\/10.3747\/co.21.2051","journal-title":"Curr Oncol"},{"issue":"1","key":"4586_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3978\/j.issn.2224-5820.2015.01.01.","volume":"4","author":"L Rowbottom","year":"2015","unstructured":"Rowbottom L, Pasetka M, McDonald R, Hunyh L, Raman S, DeAngelis C, Chow E (2015) Efficacy of granisetron and aprepitant in a patient who failed ondansetron in the prophylaxis of radiation induced nausea and vomiting: a case report. Ann Palliat Med 4(1):32\u201334. \n                    https:\/\/doi.org\/10.3978\/j.issn.2224-5820.2015.01.01.","journal-title":"Ann Palliat Med"},{"issue":"5","key":"4586_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/annonc\/mdw270","volume":"27","author":"F Roila","year":"2016","unstructured":"Roila F, Molassiotis A, Herrstedt J, Aapro M, Gralla RJ, Bruera E, Clark-Snow RA, Dupuis LL, Einhorn LH, Feyer P, Hesketh PJ, Jordan K, Olver I, Rapoport BL, Roscoe J, Ruhlmann CH, Walsh D, Warr D, van der Wetering M, participants of the MASCC\/ESMO Consensus Conference Copenhagen 2015 (2016) 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol 27(5):119\u2013133. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdw270","journal-title":"Ann Oncol"},{"issue":"28","key":"4586_CR20","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1200\/JCO.2017.74.4789","volume":"35","author":"PJ Hesketh","year":"2017","unstructured":"Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Somerfield MR, Lyman GH (2017) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35(28):3240\u20133261. \n                    https:\/\/doi.org\/10.1200\/JCO.2017.74.4789","journal-title":"J Clin Oncol"},{"key":"4586_CR21","unstructured":"Ettinger DS, Berger MJ, Ashton J, Barbour S, Bergsbaken J, Bierman P et al (2017) NCCN Guidelines Version 2.2017 Panel Members Antiemesis"},{"issue":"3","key":"4586_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.radonc.2005.07.002","volume":"76","author":"E Maranzano","year":"2005","unstructured":"Maranzano E, Feyer PC, Molassiotis A, Rossi R, Clark-Snow RA, Olver I et al (2005) Evidence-based recommendations for the use of antiemetics in radiotherapy. Radiother Oncol 76(3):227\u2013233. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2005.07.002","journal-title":"Radiother Oncol"},{"issue":"2","key":"4586_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1200\/JCO.2010.31.6414","volume":"29","author":"TK Poonacha","year":"2011","unstructured":"Poonacha TK, Go RS (2011) Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines. J Clin Oncol 29(2):186\u2013191. \n                    https:\/\/doi.org\/10.1200\/JCO.2010.31.6414","journal-title":"J Clin Oncol"},{"key":"4586_CR24","unstructured":"European Society for Medical Oncology (ESMO) Guidelines Committee (2018) SOPs\/Instructions for authors and templates for standard ESMO Clinical Practice Guidelines (CPGs) and ESMO-MCBS scores. Retrieved from \n                    https:\/\/www.esmo.org\/content\/download\/77789\/1426712\/file\/ESMO-Clinical-Practice-Guidelines-Standard-Operating-Procedures.pdf"},{"issue":"6","key":"4586_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1200\/JOP.2011.000397","volume":"7","author":"E Basch","year":"2011","unstructured":"Basch E, Hesketh PJ, Kris MG, Prestrud AA, Temin S, Lyman GH (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Oncol Pract 7(6):395\u2013398. \n                    https:\/\/doi.org\/10.1200\/jco.2010.34.4614.","journal-title":"J Oncol Pract"},{"issue":"5","key":"4586_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/annonc\/mdq194","volume":"21","author":"F Roila","year":"2010","unstructured":"Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D, On behalf of the ESMO\/MASCC Guidelines Working Group (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(5):232\u2013243. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdq194","journal-title":"Ann Oncol"},{"key":"4586_CR27","doi-asserted-by":"crossref","unstructured":"The Italian Group for Antiemetic Research in Radiotherapy (1999) Radiation-induced emesis: a prospective observational multicenter Italian trial. Int J Radiat Oncol Biol Phys 44(3):619\u2013625","DOI":"10.1016\/S0360-3016(99)00055-3"},{"issue":"2","key":"4586_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.bmt.1702479","volume":"26","author":"TR Spitzer","year":"2000","unstructured":"Spitzer TR, Friedman CJ, Bushnell W, Frankel SR, Raschko J (2000) Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation. Bone Marrow Transplant 26(2):203\u2013210. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1702479","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"4586_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s13566-012-0030-2","volume":"2","author":"K Dennis","year":"2013","unstructured":"Dennis K, Makhani L, Maranzano E, Feyer P, Zeng L, De Angelis C et al (2013) Timing and duration of 5-HT3 receptor antagonist therapy for the prophylaxis of radiotherapy-induced nausea and vomiting: a systematic review of randomized and non-randomized studies. J Radiat Oncol 2(3):271\u2013284. \n                    https:\/\/doi.org\/10.1007\/s13566-012-0030-2","journal-title":"J Radiat Oncol"},{"issue":"11","key":"4586_CR30","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00520-008-0428-y","volume":"16","author":"SG Brearley","year":"2008","unstructured":"Brearley SG, Clements CV, Molassiotis A (2008) A review of patient self-report tools for chemotherapy-induced nausea and vomiting. Support Care Cancer 16(11):1213\u20131229. \n                    https:\/\/doi.org\/10.1007\/s00520-008-0428-y","journal-title":"Support Care Cancer"},{"issue":"2","key":"4586_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00520-007-0343-7","volume":"16","author":"A Molassiotis","year":"2008","unstructured":"Molassiotis A, Saunders MP, Valle J, Wilson G, Lorigan P, Wardley A, Levine E, Cowan R, Loncaster J, Rittenberg C (2008) A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre. Support Care Cancer 16(2):201\u2013208. \n                    https:\/\/doi.org\/10.1007\/s00520-007-0343-7","journal-title":"Support Care Cancer"},{"key":"4586_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s005200100273","volume":"9","author":"G Dranitsaris","year":"2001","unstructured":"Dranitsaris G, Leung P, Warr D (2001) Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study. Support Care Cancer 9:611\u2013618. \n                    https:\/\/doi.org\/10.1007\/s005200100273","journal-title":"Support Care Cancer"},{"issue":"1","key":"4586_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejon.2004.03.006","volume":"9","author":"J Foubert","year":"2005","unstructured":"Foubert J, Vaessen G (2005) Nausea: the neglected symptom? Eur J Oncol Nurs 9(1):21\u201332. \n                    https:\/\/doi.org\/10.1016\/j.ejon.2004.03.006","journal-title":"Eur J Oncol Nurs"},{"issue":"1","key":"4586_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00520-010-1036-1","volume":"19","author":"I Olver","year":"2011","unstructured":"Olver I, Molassiotis A, Aapro M, Herrstedt J, Grunberg S, Morrow G (2011) Antiemetic research: future directions. Support Care Cancer 19(1):49\u201355. \n                    https:\/\/doi.org\/10.1007\/s00520-010-1036-1","journal-title":"Support Care Cancer"},{"issue":"9","key":"4586_CR35","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/cncr.23364","volume":"112","author":"JD Herrington","year":"2008","unstructured":"Herrington JD, Jaskiewicz AD, Song J (2008) Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting. Cancer 112(9):2080\u20132087. \n                    https:\/\/doi.org\/10.1002\/cncr.23364","journal-title":"Cancer"},{"issue":"10","key":"4586_CR36","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cncr.20230","volume":"100","author":"SM Grunberg","year":"2004","unstructured":"Grunberg SM, Deuson RR, Mavros P, Geling O, Hansen M, Cruciani G, Daniele B, de Pouvourville G, Rubenstein EB, Daugaard G (2004) Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer 100(10):2261\u20132668. \n                    https:\/\/doi.org\/10.1002\/cncr.20230","journal-title":"Cancer"},{"issue":"5","key":"4586_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1258\/jtt.2012.111201","volume":"18","author":"A Stern","year":"2012","unstructured":"Stern A, Valaitis R, Weir R, Jadad AR (2012) Use of home telehealth in palliative cancer care: a case study. J Telemed Telecare 18(5):297\u2013300. \n                    https:\/\/doi.org\/10.1258\/jtt.2012.111201","journal-title":"J Telemed Telecare"},{"issue":"10","key":"4586_CR38","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00520-010-0982-y","volume":"19","author":"C Pirri","year":"2011","unstructured":"Pirri C, Katris P, Trotter J, Bayliss E, Bennett R, Drummond P (2011) Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study. Support Care Cancer 19(10):1549\u20131563. \n                    https:\/\/doi.org\/10.1007\/s00520-010-0982-y","journal-title":"Support Care Cancer"},{"issue":"11","key":"4586_CR39","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1200\/JCO.2003.05.164","volume":"21","author":"P-B Tremblay","year":"2003","unstructured":"Tremblay P-B, Kaiser R, Sezer O, Rosler N, Schelenz C, Possinger K et al (2003) Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients. J Clin Oncol 21(11):2147\u20132155. \n                    https:\/\/doi.org\/10.1200\/JCO.2003.05.164","journal-title":"J Clin Oncol"},{"issue":"1","key":"4586_CR40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijrobp.2011.10.010","volume":"84","author":"VHF Lee","year":"2012","unstructured":"Lee VHF, Ng SCY, Leung TW, Au GKH, Kwong DLW (2012) Dosimetric predictors of radiation-induced acute nausea and vomiting in IMRT for nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 84(1):176\u2013182. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2011.10.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4586_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1470-2045(08)70313-9","volume":"10","author":"M Saito","year":"2009","unstructured":"Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, Inoue K, Kitagawa C, Ogura T, Mitsuhashi S (2009) Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. Lancet Oncol 10(2):115\u2013124. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(08)70313-9","journal-title":"Lancet Oncol"},{"issue":"6","key":"4586_CR42","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00520-014-2175-6","volume":"22","author":"M Popovic","year":"2014","unstructured":"Popovic M, Warr DG, DeAngelis C, Tsao M, Chan KKW, Poon M, Yip C, Pulenzas N, Lam H, Zhang L, Chow E (2014) Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials. Support Care Cancer 22(6):1685\u20131697. \n                    https:\/\/doi.org\/10.1007\/s00520-014-2175-6","journal-title":"Support Care Cancer"},{"key":"4586_CR43","first-page":"02","volume":"17","author":"J Dimitrijevic","year":"2009","unstructured":"Dimitrijevic J, Snezana B, Medic-Milijic N (2009) Prevention of nausea and vomiting induced by chemotherapy followed by combined chemo\/radiotherapy in head and neck cancer patients [abstract]. Support Care Cancer 17:02\u2013009","journal-title":"Support Care Cancer"},{"issue":"2","key":"4586_CR44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.21037\/apm.2018.03.12","volume":"7","author":"V Ganesh","year":"2018","unstructured":"Ganesh V, Drost L, DeAngelis C, Wan BA, Pasetka M, Chan S, Zhang L, Tsao M, Barnes E, Pulenzas N, Chung H, Zaki P, Yee C, Chow E (2018) A pilot study with palonosetron in the prophylaxis of radiation-induced nausea and vomiting. Ann Palliat Med 7(2):211\u2013220","journal-title":"Ann Palliat Med"},{"issue":"4","key":"4586_CR45","doi-asserted-by":"publisher","first-page":"385","DOI":"10.21037\/apm.2018.05.10","volume":"7","author":"V Ganesh","year":"2018","unstructured":"Ganesh V, Chan S, Zhang L, Drost L, DeAngelis C, Wan BA et al (2018) Management of radiation-induced nausea and vomiting with palonosetron in patients with pre-existing emesis: a pilot study. Ann Palliat Med 7(4):385\u2013392","journal-title":"Ann Palliat Med"},{"key":"4586_CR46","doi-asserted-by":"publisher","unstructured":"Navari RM, Nagy CK, Gray SE (2013) The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy. Support Care Cancer 21(6):1655\u20131663. \n                    https:\/\/doi.org\/10.1007\/s00520-012-1710-6.1655-1663,Jun.2013.","DOI":"10.1007\/s00520-012-1710-6.1655-1663,Jun.2013."},{"issue":"2","key":"4586_CR47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.critrevonc.2006.08.003","volume":"61","author":"K Jordan","year":"2007","unstructured":"Jordan K, Schmoll HJ, Aapro MS (2007) Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol 61(2):162\u2013175. \n                    https:\/\/doi.org\/10.1016\/J.CRITREVONC.2006.08.003","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4586-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4586-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4586-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:41:54Z","timestamp":1578012114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4586-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["4586"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4586-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"10 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}